文献速递肿瘤 PET/CT

技术演进使头颈部黑色素瘤患者检出更多前哨淋巴结

Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region.
PubMed 文献 · J Nucl Med · 2021-02-26

该回顾性研究纳入1993至2016年在荷兰癌症研究所接受前哨淋巴结活检的277例头颈部皮肤黑色素瘤患者,按技术演进分为4组。结果显示随着检测技术进步,收获的前哨淋巴结数量增加(P=0.003),每收获一枚淋巴结的手术时间减少(P=0.017),但总体假阴性率维持11.9%不变。

要点

  • 先进检测技术提高前哨淋巴结检出数量,不增加总手术时间
  • 每收获一枚淋巴结的手术时间随技术进步而减少
  • 总体假阴性率23年间维持11.9%,并发症率无显著变化

核心结论

  • 使用先进检测技术可检出更多前哨淋巴结,且不增加总手术时间,可能提示手术效率提高。
  • 每收获一枚淋巴结的手术时间减少,平均假阴性率维持11.9%且在23年间未变。
  • 术后并发症率无显著变化。

研究设计与样本

  • 回顾性数据库查询,纳入1993至2016年荷兰癌症研究所接受前哨淋巴结活检的皮肤头颈部黑色素瘤患者。
  • 按检测技术实施分为4组:1993-2005年组(n=30)、2006-2007年组(n=15)、2008-2009年组(n=40)、2010-2016年组(n=192),共277例。

主要发现

  • 全部患者均至少识别1枚前哨淋巴结,59例(21.3%)发现肿瘤阳性前哨淋巴结。
  • 各组肿瘤阳性前哨淋巴结比例:第1组33.3%(10例)、第2组20.0%(3例)、第3组15.0%(6例)、第4组20.8%(40例)。
  • 肿瘤阴性前哨淋巴结患者的区域复发导致总体假阴性率11.9%(第1组16.7%、第2组0%、第3组14.3%、第4组11.1%)。
  • 收获淋巴结数量随技术进步增加(P=0.003),Breslow厚度和每收获一枚淋巴结的手术时间减少(P=0.003和P=0.017)。

关键数值与推荐

  • 肿瘤阳性前哨淋巴结比例、总手术时间和并发症率在各组间无显著差异。

临床怎么用

  • 在头颈部黑色素瘤前哨淋巴结活检中,采用SPECT/CT、便携式γ相机和近红外荧光引导等先进技术可提高淋巴结检出数量并缩短每枚淋巴结的手术时间。
  • 尽管技术演进,假阴性率仍维持11.9%,需关注假阴性风险。

局限性

  • 回顾性研究设计。
  • 各组样本量不均衡,早期组样本量较小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sentinel lymph node (SN) biopsy (SNB) has proven to be a valuable tool for staging melanoma patients. Since its introduction in the early 1990s, this procedure has undergone several technologic refinements, including the introduction of SPECT/CT, as well as radioguidance and fluorescence guidance. The purpose of the current study was to evaluate the effect of this technologic evolution on SNB in the head and neck region. The primary endpoint was the false-negative (FN) rate. Secondary endpoints were number of harvested SNs, overall operation time, operation time per harvested SN, and postoperative complications. Methods: A retrospective database was queried for cutaneous head and neck melanoma patients who underwent SNB at The Netherlands Cancer Institute between 1993 and 2016. The implementation of new detection techniques was divided into 4 groups: 1993-2005, with preoperative lymphoscintigraphy and intraoperative use of both a γ-ray detection probe and patent blue (n = 30); 2006-2007, with addition of preoperative road maps based on SPECT/CT (n = 15); 2008-2009, with intraoperative use of a portable γ-camera (n = 40); and 2010-2016, with addition of near-infrared fluorescence guidance (n = 192). Results: In total, 277 patients were included. At least 1 SN was identified in all patients. A tumor-positive SN was found in 59 patients (21.3%): 10 in group 1 (33.3%), 3 in group 2 (20.0%), 6 in group 3 (15.0%), and 40 in group 4 (20.8%). Regional recurrences in patients with tumor-negative SNs resulted in an overall FN rate of 11.9% (group 1, 16.7%; group 2, 0%; group 3, 14.3%; group 4, 11.1%). The number of harvested nodes increased with advancing technologies (P = 0.003), whereas Breslow thickness and operation time per harvested SN decreased (P = 0.003 and P = 0.017, respectively). There was no significant difference in percentage of tumor-positive SNs, overall operation time, and complication rate between the different groups. Conclusion: The use of advanced detection technologies led to a higher number of identified SNs without an increase in overall operation time, possibly indicating an improved surgical efficiency. Operation time per harvested SN decreased; the average FN rate remained 11.9% and was unchanged over 23 y. There was no significant change in postoperative complication rate.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Berger DMS, van den Berg NS, van der Noort V, et al. Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region. J Nucl Med. 2021. PMID: 33637591. doi:10.2967/jnumed.120.246819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。